Cisen Pharmaceutical Co., Ltd. (603367.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.84B |
| Enterprise Value | 7.03B |
| P/E Ratio | 14.29 |
| PEG Ratio | -7.43 |
| Price/Sales Ratio | 1.94 |
| Price/Book Ratio | 1.03 |
| Enterprise/Revenue | 1.63 |
| Enterprise/EBITDA | 11.35 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.13 |
| Operating Margin | 0.1 |
AD
Management Effectiveness
| Return On Assets | 0.06 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 3.44B |
| Revenue/Share | 7.51 |
| Gross Profit | 1.71B |
| EBITDA | 466.28M |
| Net Income | 421.25M |
| Diluted EPS | 0.93 |
Balance Sheet
| Total Cash | 4.03B |
| Total Cash/Share | 8.9 |
| Total Debt | 373.83M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 4.53 |
| Book Value Per Share | 14.19 |
Price History
| 52-Week Change | -28.07 |
| 52-Week High | 24.85 |
| 52-Week Low | 12.13 |
| Moving Average 50 Days | 14.48 |
| Moving Average 200 Days | 15.6 |
Statistics
| Average Volume | 12.64M |
| Shares Outstanding | 452.75M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.4 |
| Trailing Annual Dividend Yield | 2.78 |
| Payout Ratio | 0.57 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
